as on September 13, 2025 at 1:29 am IST
Day's High
4.88%
Upside
52 Week's Low
52 Week's High
10.88%
Downside
946.34%
Upside
Check Theriva Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.0M
EPS (TTM)
-2.15
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-26.3M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
536900.00%
Compare market cap, revenue, PE, and other key metrics of Theriva Biologics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $4.0M | NA | NA | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Theriva Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Theriva Biologics Inc investment value today
Current value as on today
₹15,238
Returns
Returns from Theriva Biologics Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Theriva Biologics Inc. Average target price of $7
Get share price movements and forecasts by analysts on Theriva Biologics Inc.
What analysts predicted
94.14%UPSIDE
Target Price
$7
Current Price
$0.41
Analyzed by
8 Analysts
Target
$7.00
Theriva Biologics Inc target price $7, a slight upside of 94.14% compared to current price of $0.41. According to 8 analysts rating.
Search interest for Theriva Biologics Inc Stock has increased by 48% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:48% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 165.4%
Price Dip
In the last 1 month, TOVX stock has moved down by -10.3%
Organisation | Theriva Biologics Inc |
Headquarters | 9605 Medical Center Drive, Rockville, MD, United States, 20850 |
CEO | Mr. Steven A. Shallcross CPA |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Steven A. Shallcross CPA | CEO, CFO, Treasurer, Corporate Secretary & Director |
Dr. Vince Wacher Ph.D. | Head of Product & Corporate Development |
Dr. Michael Kaleko M.D., Ph.D. | Senior Vice President of Research & Development |
Dr. Ramon Alemany Ph.D. | Senior VP of Discovery & Chairman of Scientific Advisory Board |
Theriva Biologics Inc share price today is $0.41 as on at the close of the market. Theriva Biologics Inc share today touched a day high of $0.43 and a low of $0.41.
Theriva Biologics Inc share touched a 52 week high of $4.29 on and a 52 week low of $0.37 on . Theriva Biologics Inc stock price today i.e. is closed at $0.41,which is 90.44% down from its 52 week high and 12.21% up from its 52 week low.
Theriva Biologics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Theriva Biologics Inc (TOVX) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Theriva Biologics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Theriva Biologics Inc share’s latest price of $0.41 as on September 13, 2025 at 1:29 am IST, you will get 24.3902 shares of Theriva Biologics Inc. Learn more about
fractional shares .